BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
George Pentheroudakis, Georgia Raptou, Vassiliki Kotoula, Ralph M. Wirtz, Eleni Vrettou, Vasilios Karavasilis, Georgia Gourgioti, Chryssa Gakou, Konstantinos N. Syrigos, Evangelos Bournakis, Grigorios Rallis, Ioannis Varthalitis, Eleni Galani, Georgios Lazaridis, George Papaxoinis, Dimitrios Pectasides, Gerasimos Aravantinos, Thomas Makatsoris, Konstantine T. Kalogeras, George Fountzilas, Beicheng Sun. Immune Response Gene Expression in Colorectal Cancer Carries Distinct Prognostic Implications According to Tissue, Stage and Site: A Prospective Retrospective Translational Study in the Context of a Hellenic Cooperative Oncology Group Randomised TrialPLOS ONE 2015; 10(5): e0124612 doi: 10.1371/journal.pone.0124612
2
Roberto Benelli, Roberta Venè, Nicoletta Ferrari. Prostaglandin-endoperoxide synthase 2 (cyclooxygenase-2), a complex target for colorectal cancer prevention and therapyTranslational Research 2018; 196: 42 doi: 10.1016/j.trsl.2018.01.003
3
Yo Han Jeon, Ji Hyun Ahn, Hee Kyung Chang. Colorectal epithelial neoplasm associated with gut-associated lymphoid tissueJournal of Pathology and Translational Medicine 2020; 54(2): 135 doi: 10.4132/jptm.2019.11.06
4
Paul Salama, Colin Stewart, Cynthia Forrest, Cameron Platell, Barry Iacopetta. FOXP3+ cell density in lymphoid follicles from histologically normal mucosa is a strong prognostic factor in early stage colon cancerCancer Immunology, Immunotherapy 2012; 61(8): 1183 doi: 10.1007/s00262-011-1191-3